Resoimplant GmbH successfully closes third financing round

2,54 Mil. Euro for the innovative medtech company from Regensburg, Bavaria

15-Feb-2010 - Germany

Resoimplant GmbH, Regensburg, has gained a further investor – the Bavarian Investment Company (“Bayerische Beteiligungsgesellschaft”). Together with existing shareholders – S-Refit, Regensburg; High Tech Gründerfonds, Bonn; Bayern Kapital, Landshut and FVW Beteiligungsgesellschaft GmbH, Essen; the company successfully closed a 2,54 Mil. Euro financing round. The funds will be used to develop international sales and marketing as well as accelerate the new product pipeline, especially a new fixation system for use in shoulder and ankle surgery.

Resoimplant develops, manufactures and markets resorbable double shell Expansion Systems for secure fixation of tendons, ligaments and bone fragments in orthopaedic, trauma and sports medicine applications. The innovative design allows the use of an optimal polymere for the first time and assures a complete residue-free resorbtion of the implant. No second procedure to remove the implant later is necessary which minimises risk to the patient and costs to the health care system.

“This and a new design protected by over 30 patents worldwide assure a technological differentiation for Resoimplant” says BayBG Geschäftsführer Peter Pauli regarding the new investment. “In contrast to other resorbable products on the market, which are practically all copies of metal screw-type implants, the Resoimplant products are distinctly different using a patented expansion technology which has been proven in many fields in the past decades to improve the medical treatment options.”

“We are extremely pleased to be one of the very few medtech companies in Europe to close a financing round in these difficult economic conditions. Thanks to BayBG and our existing shareholders we have been able to establish the financial basis for positive and productive future of the company” explains Resoimplant general manager Robert Guilleaume. “This investment allows use to introduce our new Resofix Plus system in the key markets in the US and in Europe. In addition we can accelerate the product development pipeline to assure a timely market launch of these new systems.

https://www.bionity.com/en/news/113397/resoimplant-gmbh-successfully-closes-third-financing-round.html